INTRODUCTION:
Continuity of care for mental health patients in South Africa is often disrupted by complex service pathways, facility congestion, and medication stock-outs. The Central Chronic Medicine Dispensing and Distribution (CCMDD) programme offers an innovative mechanism to address these challenges by providing stable patients with alternative, reliable, and decongested access points for chronic medicines, including psychiatric treatments. Methods We analyzed Quarter 3 2025/26 data from the national programme, specifically isolating the cohort of patients receiving mental health treatment. Metrics reviewed included active patient enrolment, parcel dispensing trends, age distribution, and pick-up point utilization. Health systems data were triangulated with provincial feedback and monitoring and evaluation (M&E) insights to identify service accessibility challenges and formulary limitations specific to this patient group. Results The programme currently supports 31,213 mental health patients. While this represents a minority of the total 3.7 million active patients, it marks a significant increase in service linkage. Uptake is highly variable geographically, with KwaZulu-Natal accounting for the majority (18,906 patients), while other provinces lag significantly. Among the total cohort, 61% receive medicines through external pick-up points, offering a mechanism to bypass facility-associated stigma. Key barriers identified include a limited range of psychiatric medicines on the eligible formulary and inconsistent clinical reintegration of patients following facility-based reviews. Conclusion The programme demonstrates a viable proof-of-concept for decentralized medication delivery in mental health care, particularly evidenced by the scale achieved in KwaZulu-Natal. However, optimizing this model requires expanding the availability of essential mental health medicines on the formulary and building clinical confidence to support down-referral. Integrating this dispensing model more fully into national mental health strategies could significantly enhance adherence and reduce drop-out from long-term psychiatric treatment.